[artículo] 
inThe American Journal of Psychiatry > Año 2021 - Vol. 178 - No.11 (Noviembre) . - pp. 1014-1025

Título :	Amyloid and tau in alzheimer’s disease : biomarkers or molecular targets for therapy? Are we shooting the messenger?
Tipo de documento:	texto impreso
Autores:	Anand Kumar, Autor ; Charles B. Nemeroff, Autor ; Joseph J. Cooper, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 1014-1025
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Enfermedad de Alzheimer, Demencia
Resumen:	Alzheimer’s disease is a neuropsychiatric disorder with devastating clinical and socioeconomic consequences. Since the original description of the neuropathological correlates of the disorder, neuritic plaques and neurofibrillary tangles have been presumed to be critical to the underlying pathophysiology of the illness. The authors review the clinical and neuropathological origins of Alzheimer’s disease and trace the evolution of modern biomarkers from their historical roots.
Link:	./index.php?lvl=notice_display&id=27895

[artículo] Amyloid and tau in alzheimer’s disease : biomarkers or molecular targets for therapy? Are we shooting the messenger? [texto impreso] / Anand Kumar, Autor ; Charles B. Nemeroff, Autor ; Joseph J. Cooper, Autor . - 2022 . - pp. 1014-1025.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.11 (Noviembre) . - pp. 1014-1025

Palabras clave:	Enfermedad de Alzheimer, Demencia
Resumen:	Alzheimer’s disease is a neuropsychiatric disorder with devastating clinical and socioeconomic consequences. Since the original description of the neuropathological correlates of the disorder, neuritic plaques and neurofibrillary tangles have been presumed to be critical to the underlying pathophysiology of the illness. The authors review the clinical and neuropathological origins of Alzheimer’s disease and trace the evolution of modern biomarkers from their historical roots.
Link:	./index.php?lvl=notice_display&id=27895